Growth Metrics

Armata Pharmaceuticals (ARMP) Research & Development: 2013-2018

Historic Research & Development for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to $2.0 million.

  • Armata Pharmaceuticals' Research & Development rose 82.02% to $2.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $7.2 million, marking a year-over-year decrease of 22.51%. This contributed to the annual value of $34.4 million for FY2024, which is 1.94% up from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Research & Development of $2.0 million as of Q4 2018, which was up 3.60% from $1.9 million recorded in Q3 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Research & Development peaked at $5.6 million during Q4 2016, and registered a low of $41,000 during Q3 2016.
  • In the last 3 years, Armata Pharmaceuticals' Research & Development had a median value of $1.7 million in 2017 and averaged $1.9 million.
  • Examining YoY changes over the last 5 years, Armata Pharmaceuticals' Research & Development showed a top increase of 356.87% in 2016 and a maximum decrease of 94.37% in 2016.
  • Quarterly analysis of 5 years shows Armata Pharmaceuticals' Research & Development stood at $1.1 million in 2014, then grew by 9.16% to $1.2 million in 2015, then spiked by 356.87% to $5.6 million in 2016, then tumbled by 80.36% to $1.1 million in 2017, then soared by 82.02% to $2.0 million in 2018.
  • Its last three reported values are $2.0 million in Q4 2018, $1.9 million for Q3 2018, and $2.2 million during Q2 2018.